PMID- 31647393
OWN - NLM
STAT- MEDLINE
DCOM- 20201005
LR  - 20211204
IS  - 1875-5739 (Electronic)
IS  - 1567-2026 (Linking)
VI  - 16
IP  - 5
DP  - 2019
TI  - Dissecting the Biological Effects of Isoflurane through the Mechanistic Target of 
      Rapamycin (mTOR) and microRNAs (miRNAs).
PG  - 403-404
LID - 10.2174/1567202616999191024151901 [doi]
FAU - Maiese, Kenneth
AU  - Maiese K
AD  - New York NY, United States.
LA  - eng
PT  - Editorial
PL  - United Arab Emirates
TA  - Curr Neurovasc Res
JT  - Current neurovascular research
JID - 101208439
RN  - 0 (Anesthetics, Inhalation)
RN  - 0 (MicroRNAs)
RN  - CYS9AKD70P (Isoflurane)
RN  - EC 2.7.11.1 (TOR Serine-Threonine Kinases)
SB  - IM
MH  - Anesthetics, Inhalation/*pharmacology
MH  - Animals
MH  - Brain/drug effects/metabolism
MH  - Humans
MH  - Isoflurane/*pharmacology
MH  - MicroRNAs
MH  - TOR Serine-Threonine Kinases/*metabolism
EDAT- 2019/10/28 06:00
MHDA- 2020/10/06 06:00
CRDT- 2019/10/25 06:00
PHST- 2019/10/28 06:00 [pubmed]
PHST- 2020/10/06 06:00 [medline]
PHST- 2019/10/25 06:00 [entrez]
AID - CNR-EPUB-101869 [pii]
AID - 10.2174/1567202616999191024151901 [doi]
PST - ppublish
SO  - Curr Neurovasc Res. 2019;16(5):403-404. doi: 10.2174/1567202616999191024151901.